Development and Validation of Analytical HPLC Method for Identification and Assay of Enoxaparin Sodium in Injectable Preparations
Introduction. Enoxaparin sodium-containing drugs are included in relevant protocols for COVID-19 therapy. An increase in the production volume of such drugs leads to a demand for available and precise methods of identification and quantitative measurement of the active ingredient in the preparations...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2023-02-01
|
| Col·lecció: | Разработка и регистрация лекарственных средств |
| Matèries: | |
| Accés en línia: | https://www.pharmjournal.ru/jour/article/view/1438 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|